256 related articles for article (PubMed ID: 25326022)
1. Candesartan attenuates ischemic brain edema and protects the blood-brain barrier integrity from ischemia/reperfusion injury in rats.
Panahpour H; Nekooeian AA; Dehghani GA
Iran Biomed J; 2014; 18(4):232-8. PubMed ID: 25326022
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic effects of postischemic treatment with hypotensive doses of an angiotensin II receptor blocker on transient focal cerebral ischemia.
Fu H; Hosomi N; Pelisch N; Nakano D; Liu G; Ueno M; Miki T; Masugata H; Sueda Y; Itano T; Matsumoto M; Nishiyama A; Kohno M
J Hypertens; 2011 Nov; 29(11):2210-9. PubMed ID: 21934531
[TBL] [Abstract][Full Text] [Related]
3. Comparison between early and delayed systemic treatment with candesartan of rats after ischaemic stroke.
Brdon J; Kaiser S; Hagemann F; Zhao Y; Culman J; Gohlke P
J Hypertens; 2007 Jan; 25(1):187-96. PubMed ID: 17143191
[TBL] [Abstract][Full Text] [Related]
4. Contribution of nitric oxide synthase (NOS) activity in blood-brain barrier disruption and edema after acute ischemia/reperfusion in aortic coarctation-induced hypertensive rats.
Mohammadi MT; Shid Moosavi SM; Dehghani GA
Iran Biomed J; 2011; 15(1-2):22-30. PubMed ID: 21725496
[TBL] [Abstract][Full Text] [Related]
5. Intra-artery infusion of recombinant human erythropoietin reduces blood-brain barrier disruption in rats following cerebral ischemia and reperfusion.
Wang R; Wu X; Liang J; Qi Z; Liu X; Min L; Ji X; Luo Y; Zhao H
Int J Neurosci; 2015; 125(9):693-702. PubMed ID: 25226558
[TBL] [Abstract][Full Text] [Related]
6. Protective mechanisms of the angiotensin II type 1 receptor blocker candesartan against cerebral ischemia: in-vivo and in-vitro studies.
Liu H; Kitazato KT; Uno M; Yagi K; Kanematsu Y; Tamura T; Tada Y; Kinouchi T; Nagahiro S
J Hypertens; 2008 Jul; 26(7):1435-45. PubMed ID: 18551021
[TBL] [Abstract][Full Text] [Related]
7. Effect of aminoguanidine on post-ischemic brain edema in transient model of focal cerebral ischemia.
Vakili A; Hosseinzadeh F; Sadogh T
Brain Res; 2007 Sep; 1170():97-102. PubMed ID: 17698046
[TBL] [Abstract][Full Text] [Related]
8. The protective effect of HET0016 on brain edema and blood-brain barrier dysfunction after cerebral ischemia/reperfusion.
Liu Y; Wang D; Wang H; Qu Y; Xiao X; Zhu Y
Brain Res; 2014 Jan; 1544():45-53. PubMed ID: 24316243
[TBL] [Abstract][Full Text] [Related]
9. Magnesium sulfate protects blood-brain barrier integrity and reduces brain edema after acute ischemic stroke in rats.
Shadman J; Sadeghian N; Moradi A; Bohlooli S; Panahpour H
Metab Brain Dis; 2019 Aug; 34(4):1221-1229. PubMed ID: 31037556
[TBL] [Abstract][Full Text] [Related]
10. A comparative study of neuroprotective effect of single and combined blockade of AT1 receptor and PARP-1 in focal cerebral ischaemia in rat.
Singh N; Sharma G; Singh N; Hanif K
Int J Stroke; 2014 Jul; 9(5):560-8. PubMed ID: 23013350
[TBL] [Abstract][Full Text] [Related]
11. Protective effect of endothelin type A receptor antagonist on brain edema and injury after transient middle cerebral artery occlusion in rats.
Matsuo Y; Mihara Si ; Ninomiya M; Fujimoto M
Stroke; 2001 Sep; 32(9):2143-8. PubMed ID: 11546909
[TBL] [Abstract][Full Text] [Related]
12. Effects of nicorandil on neurobehavioral function, BBB integrity, edema and stereological parameters of the brain in the sub-acute phase of stroke in a rat model.
Owjfard M; Bigdeli MR; Safari A; Namavar MR
J Biosci; 2020; 45():. PubMed ID: 32345775
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotective effects of AT1 receptor antagonists after experimental ischemic stroke: what is important?
Culman J; Jacob T; Schuster SO; Brolund-Spaether K; Brolund L; Cascorbi I; Zhao Y; Gohlke P
Naunyn Schmiedebergs Arch Pharmacol; 2017 Sep; 390(9):949-959. PubMed ID: 28669009
[TBL] [Abstract][Full Text] [Related]
14. Attenuation of focal cerebral ischemic injury following post-ischemic inhibition of angiotensin converting enzyme (ACE) activity in normotensive rat.
Panahpour H; Dehghani GA
Iran Biomed J; 2012; 16(4):202-8. PubMed ID: 23183619
[TBL] [Abstract][Full Text] [Related]
15. Effect of angiotensin II type 1 receptor blocker, candesartan, and beta 1 adrenoceptor blocker, atenolol, on brain damage in ischemic stroke.
Saad MA; Abbas AM; Boshra V; Elkhateeb M; El Aal IA
Acta Physiol Hung; 2010 Jun; 97(2):159-71. PubMed ID: 20511125
[TBL] [Abstract][Full Text] [Related]
16. Tetramethylpyrazine-2'-O-sodium ferulate attenuates blood-brain barrier disruption and brain oedema after cerebral ischemia/reperfusion.
Xu SH; Yin MS; Liu B; Chen ML; He GW; Zhou PP; Cui YJ; Yang D; Wu YL
Hum Exp Toxicol; 2017 Jul; 36(7):670-680. PubMed ID: 27387348
[TBL] [Abstract][Full Text] [Related]
17. Early VEGF inhibition attenuates blood-brain barrier disruption in ischemic rat brains by regulating the expression of MMPs.
Zhang HT; Zhang P; Gao Y; Li CL; Wang HJ; Chen LC; Feng Y; Li RY; Li YL; Jiang CL
Mol Med Rep; 2017 Jan; 15(1):57-64. PubMed ID: 27909732
[TBL] [Abstract][Full Text] [Related]
18. Postischemic administration of angiotensin II type 1 receptor blocker reduces cerebral infarction size in hypertensive rats.
Omura-Matsuoka E; Yagita Y; Sasaki T; Terasaki Y; Oyama N; Sugiyama Y; Okazaki S; Sakoda S; Kitagawa K
Hypertens Res; 2009 Jul; 32(7):548-53. PubMed ID: 19424281
[TBL] [Abstract][Full Text] [Related]
19. Comparison of inhibitory action of candesartan and enalapril on brain ischemia through inhibition of oxidative stress.
Hamai M; Iwai M; Ide A; Tomochika H; Tomono Y; Mogi M; Horiuchi M
Neuropharmacology; 2006 Sep; 51(4):822-8. PubMed ID: 16824557
[TBL] [Abstract][Full Text] [Related]
20. Candesartan pretreatment is cerebroprotective in a rat model of endothelin-1-induced middle cerebral artery occlusion.
Mecca AP; O'Connor TE; Katovich MJ; Sumners C
Exp Physiol; 2009 Aug; 94(8):937-46. PubMed ID: 19429641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
